2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors

Berman M, Weiss MF (1967) SAAM Manual NIH, PHS Publication 1703, Bethesda, Maryland, USA

Bockaert, J, Nelson DL, Herbet A, Adrien J, Enjalbert A, Hamon M (1981) In: Haber B, Gabay S, Issidorides M, Alivisatos S (eds) Serotonin: Current aspects of neurochemistry and function. Plenum Press, New York, pp 327?345

Bradley PB, Humphrey PPA, Williams RH (1983) Are vascular ?D? and ?5HT2? receptors for 5-hydroxytryptamine the same? Br J Pharmacol 295P

Closse A (1983) [3H]mesulergine, a selective ligand for serotonin-2-receptors. Life Sci 32:2485?2495

Cohen ML, Fuller RW, Wiley KS (1981) Evidence for 5HT2 receptors mediating contraction in vascular smooth muscle. J Pharmacol Exp Ther 218:421?425

Engel G, Hoyer D (1981) [125I]BE 2254, a new high affinity radioligand for ?1-adrenoceptors. Eur J Pharmacol 73:221?224

Engel G, Hoyer D, Berthold R, Wagner H (1981) (±)[125Iodo]-cyanopindolol, a new ligand for ?-adrenoceptors: Identification and quantitation of subclasses of ?-adrenoceptors in guinea pig. Naunyn-Schmiedeberg's Arch Pharmacol 317:277?285

Engel G, Müller-Schweinitzer E, Stadler P (1983a) (125I)LSD, a new ligand with selectivity for 5HT2 receptors. Br J Pharmacol 78:83P

Engel G, Göthert M, Müller-Schweinitzer E, Schlicker E, Sistonen L, Stadler PA (1983b) Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors in sympathetic nerves. Naunyn-Schmiedeberg's Arch Pharmacol 324:116?124

Engel G, v Amsterdam F, Palacios JM (1983c) 125I-LSD, a new useful ligand for the characterisation and localisation of 5-HT receptors. Naunyn-Schmiedeberg's Arch Pharmacol 322:R92

Enna SJ, Bennet JP, Burt DR, Creese I, Snyder SH (1976) Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency. Nature 263:338?341

Fozard JR (1983) Functional correlates of 5HT1 recognition sites. Trends Pharmacol Sci 4:288?289

Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br J Pharmacol 12:323?328

Geaney DP, Schachter JM, Elliott JM, Graham-Smith DG (1983) Specific binding of [3H]lysergic acid diethylamide (LSD) to human platelet membranes. Br J Pharmacol 78:82P

Görich R, Weihrauch TR, Kilbinger H (1982) The inhibition by dopamine of cholinergic transmission in the isolated guinea pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 318:308?312

Göthert M, Schlicker E (1983) Autoreceptor-mediated inhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine. Life Sci 32:1183?1191

Goldberg LI, Volkman PH, Kohli JD (1978) A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol 18:57?79

Hamon M (1983) Radioactive ligand binding studies: Identification of central serotonin receptors. In: Marangos PJ (ed) Methods in neurobiology. Plenum Publication Corporation, New York, in press

Hartig PR, Kadan MJ, Evans MJ, Krohn AM (1983) 125I-LSD: a high selectivity ligand for serotonin receptors. Eur J Pharmacol 89:321?323

König JFR, Klippel RA (1963) The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem. Williams and Wilkins, Baltimore, M.D., USA

Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R 41468, a novel antagonist at 5HT2 receptors. Life Sci 28:1015?1022

Leysen JE, Gommeren W, De Clerck F (1983) Demonstration of S2-receptor binding sites on cat blood platelets using [3H]-ketanserin. Eur J Pharmacol 88:125?130

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265?275

Martin LL, Sanders-Bush E (1982) Comparison of the pharmacological characteristics of 5HT1 and 5HT2 binding sites with those of 5HT autoreceptors which modulate serotonin release. Naunyn-Schmiedeberg's Arch Pharmacol 321:165?170

Meibach RC, Maayani S, Green JP (1980) Characterization and radioautography of (3H)LSD binding by rat brain slices in vitro: The effect of 5-hydroxytryptamine. Eur J Pharmacol 67:371?382

Müller-Schweinitzer E (1982) Actions of Co-dergocrine mesylate and its components at vascular smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 318:225?233

Müller-Schweinitzer E, Engel G (1983) Evidence for mediation by 5HT1 receptors of 5HT-induced contraction of canine basilar artery. Naunyn-Schmiedeberg's Arch Pharmacol 324:287?292

Nelson DL, Schnellmann R, Smit M (1983) 3H-serotonin binding sites: Pharmacological and species differences. In: Segawa T, Yamamura HI, Kuriyama K (eds) Molecular pharmacology of neurotransmitter receptors. Raven Press, New York, pp 103?113

Nueten JM Van, Vanhoutte PM (1981) Selectivity of Ca++-antagonism and 5HT-antagonism with respect to venous and arterial tissues. Angiology 32:476?484

Ortmann R, Bischoff S, Radeke E, Buech O, Delini Stula A (1982) Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers. Naunyn-Schmiedeberg's Arch Pharmacol 321:265?270

Palacios JM (1983a) Quantitative receptor autoradiography: Application to the study of multiple serotonin receptors in rat cortex. In: Mandel P, De Feudis FV (eds) CNS receptors from molecular pharmacology to behavior. Raven Press, New York, 455?463

Palacios JM (1983b) Light microscopic autoradiographic localization of catecholamine receptor binding sites in brain: Problems of ligand specificity and use of new ligands. In: Usdin E (ed) Proceedings of the fifth international catecholamine symposium, Göteborg 1983. Alan R. Liss Inc., New York, in press

Palacios JM, Niehoff DL, Kuhar MJ (1981) [3H]spiperone binding sites in brain: autoradiographic localization of multiple receptors. Brain Res 213:277?289

Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]5-hydroxytryptamine binding sites by neuroleptic spiperone in rat brain. J Neurochem 36:220?226

Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors differential binding of [3H]-5-hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol. Mol Pharmacol 16:687?699

Peroutka SJ, Lebovitz RM, Snyder SH (1979) Serotonin receptor binding sites affected differentially by guanine nucleotides. Mol Pharmacol 16:700?708

Peroutka SJ, Noguchi M, Tolner DJ, Allen G (1983) Serotonin-induced contraction of canine basilar artery: Mediation by 5HT1 receptors. Brain Res 259:327?330

Rutschmann J, Stadler PA (1978) Chemical background. In: Berde B, Schild HO (eds) Handbook of experimental pharmacology 49, Ergot alkaloids and related compounds. Springer, Berlin Heidelberg New York, pp 29?86

Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32:229?313

Snedecor GW, Cochran WG (1973) Curvilinear regression. In: Snedecor GW, Cochran CG (eds) Statistic methods, chapt 15. The Iowa State University Press, 6th Edition, Ames, Iowa, USA, pp 447?471

Stoll A, Hofmann A (1943) Partialsynthese von Alkaloiden vom Typus des Ergobasins. Helv Chim Acta 26:944?965

Tobler HJ, Engel G (1983) Affinity spectra: A novel way for the evaluation of equilibrium binding experiments. Naunyn-Schmiedeberg's Arch Pharmacol 322:182?192

Troxler F, Hofmann A (1957) Substitution am Ringsystem der Lysergsäure. III. Halogenierung. Helv Chim Acta 40:2160?2170

Xue QF, Maurer R, Engel G (1983) Selective distribution of ?- and ?1-adrenoceptors in rat lung visualized by autoradiography. Arch Int Pharmacodyn Ther 266:308?314